trial
as of 2026-07-01Clozapine Plasma Levels and the Relationship to the Genetic Polymorphism in Shizophrenic Patients
NCTId NCT01663077
at a glance
Phase 4 · Completed
Enrollment 20 (actual)
Sponsored by Tirat Carmel Mental Health Center
Primary completion 2016-11
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
20 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2012-10
Primary completion
2016-11
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Drugs
Indications
Sponsors
Tirat Carmel Mental Health CenterLead Sponsor
Technion, Israel Institute of TechnologyCollaborator
Ben-Gurion University of the NegevCollaborator
Beersheva Mental Health CenterCollaborator
Sha'ar Menashe Mental Health CenterCollaborator
HaEmek Medical Center, IsraelCollaborator
The Nazareth Hospital, IsraelCollaborator
Investigators
8
Anatoly Kreinin, MD, PhdStudy Director
Yedidia Bentur, MDPrincipal Investigator
Norberto Krivoy, MDPrincipal Investigator
David Rabinowitz, MDPrincipal Investigator
Kamal Farhat, MDPrincipal Investigator
Prof. Vladimir Lerner, MD, PhDPrincipal Investigator
Boaz Bloch, MDPrincipal Investigator
Alexander Grinshpoon, MD, MHA, PhDPrincipal Investigator
Sites
1 total
Tirat Carmel, Israel
Facts & assertions
4 sourced
Enrollment
20
Phase
PHASE4
Primary Completion Date
2016-11
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
collaborator
indication
indication
indication
investigator
person
person
person
person